Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Early Alzheimer's Disease
NCT07172815Phase 2Not yet recruiting
- Sponsor
- Imperial College London
- Start
- Sep 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tadalafil in Alzheimer's disease (AD), sponsored by Imperial College London. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
tadalafil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07172815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07172815.